Can attention training improve sleep, anxiety, and mood?

Not Applicable

Completed

• Conditions: Insomnia; Anxiety; Depression; Mental Health - Anxiety; Mental Health - Depression; Mental Health - Other mental health disorders

• Registration Number: ACTRN12616000346471
• Lead Sponsor: St Vincent's Hospital Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Self-identified as suffering from insomnia and anxiety/depression, with worry as a contributing factor to their insomnia.
- Meet criteria for insomnia on ISI and time frames outlined in DSM-5.
- Meet threshold for Generalised Anxiety Disorder on GAD-7, or meet threshold for depression on PHQ-9, without thoughts of self-harm/suicidal intent.
- Australian resident status.
- At least 18 years of age.
- Have reliable access to a computer and the internet.
- Prepared to provide name, phone number, and address, and to provide the name and phone number of a local general practitioner.
- Willing to provide informed consent.

Exclusion Criteria

- Presence of severe depression and/or suicidal ideation.
- Lifetime history of psychosis/bipolar disorder.
- Current substance abuse/use of Benzodiazepines or antipsychotic medications.
- Presence of untreated sleep disorder other than insomnia.
- Initiation/change of medication, or initiation of psychological therapy in the last 2 months.
- Engagement in shift work/presence of commitments that interfere with regular night-time sleep patterns.
- Waking time outside of 4-10am and bed time outside of 8pm-2pm more than twice a week, not primarily due to insomnia.
- Not fluent in written and spoken English.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in insomnia symptoms according to scores on the Insomnia Severity Index (ISI)[Administered at Baseline (T1), Post-ABM intervention (T2, 1 week after baseline), and at 1 month follow-up (T3).]